Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes

X. Gai, M. G. Rizzo, J. Lee, A. Ullrich, R. Baserga

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Two constructs (co-transfected with selectable markers) were used to establish cell lines from BALB/c3T3 cells: a p53 mini-gene under the control of an LTR promoter and a synthetic IGF-1 coding sequence driven by the SV40 early promoter. BALB/c3T3 cells do not grow in plasma or in 1% serum or in soft agar and in defined media require both platelet-derived growth factor (PDGF) and insulin (or IGF-1). Cells carrying only the LTR/p53 mini-gene grew well in plasma (but not in 1% serum), in soft agar and in serum-free medium containing only insulin. Cells carrying only the SV40/IGF-1 gene grew (but not too vigorously) in soft agar and grew well in serum-free medium containing PDGF but no insulin. Cells carrying both constructs grew very well in plasma, in soft agar and in serum-free medium without PDGF nor insulin. The results indicate that the requirements for growth of BALB/c3T3 cells can be reduced to two genes: IGF-1 and a gene replacing PDGF (p53 in our case). An unexpected, but interesting observation was that cells carrying the LTR/p53 gene grew slower in 10% serum than in plasma.

Original languageEnglish
Pages (from-to)377-386
Number of pages10
JournalOncogene Research
Volume3
Issue number4
Publication statusPublished - 1988

Fingerprint

3T3 Cells
Insulin-Like Growth Factor I
Intercellular Signaling Peptides and Proteins
Platelet-Derived Growth Factor
Agar
p53 Genes
Serum-Free Culture Media
Genes
Insulin
Serum
Observation
Cell Line
Growth

ASJC Scopus subject areas

  • Cancer Research

Cite this

Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes. / Gai, X.; Rizzo, M. G.; Lee, J.; Ullrich, A.; Baserga, R.

In: Oncogene Research, Vol. 3, No. 4, 1988, p. 377-386.

Research output: Contribution to journalArticle

@article{d2f3707b737e421ea93d7a0e0d5ea627,
title = "Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes",
abstract = "Two constructs (co-transfected with selectable markers) were used to establish cell lines from BALB/c3T3 cells: a p53 mini-gene under the control of an LTR promoter and a synthetic IGF-1 coding sequence driven by the SV40 early promoter. BALB/c3T3 cells do not grow in plasma or in 1{\%} serum or in soft agar and in defined media require both platelet-derived growth factor (PDGF) and insulin (or IGF-1). Cells carrying only the LTR/p53 mini-gene grew well in plasma (but not in 1{\%} serum), in soft agar and in serum-free medium containing only insulin. Cells carrying only the SV40/IGF-1 gene grew (but not too vigorously) in soft agar and grew well in serum-free medium containing PDGF but no insulin. Cells carrying both constructs grew very well in plasma, in soft agar and in serum-free medium without PDGF nor insulin. The results indicate that the requirements for growth of BALB/c3T3 cells can be reduced to two genes: IGF-1 and a gene replacing PDGF (p53 in our case). An unexpected, but interesting observation was that cells carrying the LTR/p53 gene grew slower in 10{\%} serum than in plasma.",
author = "X. Gai and Rizzo, {M. G.} and J. Lee and A. Ullrich and R. Baserga",
year = "1988",
language = "English",
volume = "3",
pages = "377--386",
journal = "Oncogene Research",
issn = "0890-6467",
number = "4",

}

TY - JOUR

T1 - Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes

AU - Gai, X.

AU - Rizzo, M. G.

AU - Lee, J.

AU - Ullrich, A.

AU - Baserga, R.

PY - 1988

Y1 - 1988

N2 - Two constructs (co-transfected with selectable markers) were used to establish cell lines from BALB/c3T3 cells: a p53 mini-gene under the control of an LTR promoter and a synthetic IGF-1 coding sequence driven by the SV40 early promoter. BALB/c3T3 cells do not grow in plasma or in 1% serum or in soft agar and in defined media require both platelet-derived growth factor (PDGF) and insulin (or IGF-1). Cells carrying only the LTR/p53 mini-gene grew well in plasma (but not in 1% serum), in soft agar and in serum-free medium containing only insulin. Cells carrying only the SV40/IGF-1 gene grew (but not too vigorously) in soft agar and grew well in serum-free medium containing PDGF but no insulin. Cells carrying both constructs grew very well in plasma, in soft agar and in serum-free medium without PDGF nor insulin. The results indicate that the requirements for growth of BALB/c3T3 cells can be reduced to two genes: IGF-1 and a gene replacing PDGF (p53 in our case). An unexpected, but interesting observation was that cells carrying the LTR/p53 gene grew slower in 10% serum than in plasma.

AB - Two constructs (co-transfected with selectable markers) were used to establish cell lines from BALB/c3T3 cells: a p53 mini-gene under the control of an LTR promoter and a synthetic IGF-1 coding sequence driven by the SV40 early promoter. BALB/c3T3 cells do not grow in plasma or in 1% serum or in soft agar and in defined media require both platelet-derived growth factor (PDGF) and insulin (or IGF-1). Cells carrying only the LTR/p53 mini-gene grew well in plasma (but not in 1% serum), in soft agar and in serum-free medium containing only insulin. Cells carrying only the SV40/IGF-1 gene grew (but not too vigorously) in soft agar and grew well in serum-free medium containing PDGF but no insulin. Cells carrying both constructs grew very well in plasma, in soft agar and in serum-free medium without PDGF nor insulin. The results indicate that the requirements for growth of BALB/c3T3 cells can be reduced to two genes: IGF-1 and a gene replacing PDGF (p53 in our case). An unexpected, but interesting observation was that cells carrying the LTR/p53 gene grew slower in 10% serum than in plasma.

UR - http://www.scopus.com/inward/record.url?scp=0024245123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024245123&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 377

EP - 386

JO - Oncogene Research

JF - Oncogene Research

SN - 0890-6467

IS - 4

ER -